News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Utilizing Turbine and Harmonic Discovery Pair Simulation Alongside Expertise in Multi-Target Kinase Inhibition Chemistry for the Development of a Novel Cancer Therapy
Monday, April 01, 2024Turbine a company pioneering the development of the worlds first predictive simulation of patient biology
Gilead and Xilio Enter Exclusive License Agreement for Tumor-Activated IL-12 Program
Saturday, March 30, 2024Gilead Sciences Inc and Xilio Therapeutics Inc have recently announced an exclusive agreement to collaborate on the development and commercialization of Xilios Phase tumoractivated IL program
Confo Therapeutics Secures VLAIO Grant for Advancing Drug Discovery and Development in Endocrine and Metabolic Diseases
Friday, March 29, 2024Confo Therapeutics a pioneer in the field of developing innovative medicines targeting Gprotein coupled receptors has announced today that it has received a substantial EUR million grant from Flanders
Intravacc and Primrose Bio Collaborate to Enhance Conjugate Vaccine Development
Thursday, March 28, 2024Intravacc a globally recognized contract development and manufacturing organization specializing in infectious disease and therapeutic vaccines has announced a strategic partnership with Primrose Bio
Slingshot Introduces Novel Portfolio Aimed at Advancing Cell Therapy Development, Manufacturing, and Clinical Trials
Wednesday, March 27, 2024In response to significant customer demand Slingshot Biosciences is unveiling a revolutionary range of products aimed at transforming the landscape of analytical precision in cell therapy
Essential Pharma and AcedrA Biopharmaceuticals Announce Distribution Agreement to Market Vital Medications in the Middle East and North Africa Region
Wednesday, March 27, 2024Essential Pharma a global specialty pharmaceutical group dedicated to ensuring sustainable access to
Brain Trust Bio Granted Approval for Clinical Trials on ALS and Other CNS Disorders Utilizing Continuous Intrathecal Drug Delivery Approach
Tuesday, March 26, 2024Brain Trust Bio a leading innovator in developing treatments for central nervous system disorders has obtained approval to initiate Phase I clinical trials in Australia for its revolutionary Continuous
Andelyn Biosciences and Grace Science, LLC Join Forces to Transfer Technology for Suspensive Process AAV Gene Therapy for NGLY1 Deficiency
Monday, March 25, 2024Andelyn Biosciences Inc a leading Contract Development and Manufacturing Organization specializing in cell and gene therapy has partnered with Grace Science LLC to facilitate the tech transfer
Mission Therapeutics Initiates Landmark Trial for MTX325, a Promising Therapy for Parkinson’s Disease
Friday, March 22, 2024Mission Therapeutics a biotech company in the clinical stage has initiated the Phase I firstinhuman clinical trial of MTX its promising treatment aimed at modifying Parkinsons Disease
HI-Bio Granted FDA Orphan Drug Designation for Felzartamab in Treating Antibody-Mediated Rejection in Kidney Transplant Recipients
Friday, March 22, 2024Human Immunology Biosciences a biotechnology company in the clinical stages of development has recently announced that the US Food and Drug Administration has granted Orphan Drug Designation
